"4"^^ . . "Serious cutaneous toxicity following ifosfamide, gemcitabine and vinorelbine therapy in a patient with relapsed Hodgkin lymphoma and ichthyosis]"@en . "11110" . "Z\u00E1va\u017En\u00E1 ko\u017En\u00ED toxicita po l\u00E9\u010Db\u011B ifosfamidem, gemcitabinem a vinorelbinem u pacienta s relapsem Hodgkinova lymfomu a ichty\u00F3zou"@cs . . "Z\u00E1va\u017En\u00E1 ko\u017En\u00ED toxicita po l\u00E9\u010Db\u011B ifosfamidem, gemcitabinem a vinorelbinem u pacienta s relapsem Hodgkinova lymfomu a ichty\u00F3zou"@cs . "U 47let\u00E9ho pacienta s dlouholetou anamn\u00E9zou ichty\u00F3zy byl biopticky prok\u00E1z\u00E1n klasick\u00FD Hodgkin\u016Fv lymfom. Pacient byl v \u00FAvodu l\u00E9\u010Den \u0161esti cykly kombinovan\u00E9 chemoterapie. Patn\u00E1ct m\u011Bs\u00EDc\u016F po ukon\u010Den\u00ED l\u00E9\u010Dby byl diagnostikov\u00E1n relaps Hodgkinova lymfomu. Pacient byl \u00FAsp\u011B\u0161n\u011B l\u00E9\u010Den \u0161esti cykly chemoterapie s n\u00E1slednou radioterapi\u00ED. Prvn\u00ED ani druh\u00E1 chemoterapie nevedly k z\u00E1va\u017En\u00E9 ko\u017En\u00ED toxicit\u011B. P\u0159ibli\u017En\u011B po \u010Dty\u0159ech letech od ukon\u010Den\u00ED druh\u00E9 linie l\u00E9\u010Dby byl u pacienta diagnostikov\u00E1n druh\u00FD relaps Hodgkinova lymfomu. Pacient byl l\u00E9\u010Den t\u0159emi cykly chemoterapie obsahuj\u00EDc\u00ED ifosfamid, gemcitabin, vinorelbin a prednison. Po ka\u017Ed\u00E9m cyklu t\u00E9to l\u00E9\u010Dby do\u0161lo k rozvoji t\u011B\u017Ek\u00E9 neutropenie (WHO 4) s n\u00E1slednou t\u011B\u017Ekou difuzn\u00ED toxoalergickou ko\u017En\u00ED reakc\u00ED a s bul\u00F3zn\u00EDm eryt\u00E9mem. M\u00EDsty bylo mo\u017Eno hodnotit ko\u017En\u00ED zm\u011Bny a\u017E stupn\u011Bm 3 a 4 dle WHO. Stav jsme hodnotili jako kombinovan\u00FD toxick\u00FD \u00FA\u010Dinek gemcitabinu a vinorelbinu v ter\u00E9nu k\u016F\u017Ee po\u0161kozen\u00E9 preexistuj\u00EDc\u00ED ichty\u00F3zou. Po odezn\u011Bn\u00ED ko\u017En\u00ED toxicity bylo zbytkov\u00E9 uzlinov\u00E9 posti\u017Een\u00ED oz\u00E1\u0159eno." . . "148" . "Kon\u00ED\u0159ov\u00E1, Eva" . "M\u00F3cikov\u00E1, Heidi" . . "Z(MSM0021620808)" . "U 47let\u00E9ho pacienta s dlouholetou anamn\u00E9zou ichty\u00F3zy byl biopticky prok\u00E1z\u00E1n klasick\u00FD Hodgkin\u016Fv lymfom. Pacient byl v \u00FAvodu l\u00E9\u010Den \u0161esti cykly kombinovan\u00E9 chemoterapie. Patn\u00E1ct m\u011Bs\u00EDc\u016F po ukon\u010Den\u00ED l\u00E9\u010Dby byl diagnostikov\u00E1n relaps Hodgkinova lymfomu. Pacient byl \u00FAsp\u011B\u0161n\u011B l\u00E9\u010Den \u0161esti cykly chemoterapie s n\u00E1slednou radioterapi\u00ED. Prvn\u00ED ani druh\u00E1 chemoterapie nevedly k z\u00E1va\u017En\u00E9 ko\u017En\u00ED toxicit\u011B. P\u0159ibli\u017En\u011B po \u010Dty\u0159ech letech od ukon\u010Den\u00ED druh\u00E9 linie l\u00E9\u010Dby byl u pacienta diagnostikov\u00E1n druh\u00FD relaps Hodgkinova lymfomu. Pacient byl l\u00E9\u010Den t\u0159emi cykly chemoterapie obsahuj\u00EDc\u00ED ifosfamid, gemcitabin, vinorelbin a prednison. Po ka\u017Ed\u00E9m cyklu t\u00E9to l\u00E9\u010Dby do\u0161lo k rozvoji t\u011B\u017Ek\u00E9 neutropenie (WHO 4) s n\u00E1slednou t\u011B\u017Ekou difuzn\u00ED toxoalergickou ko\u017En\u00ED reakc\u00ED a s bul\u00F3zn\u00EDm eryt\u00E9mem. M\u00EDsty bylo mo\u017Eno hodnotit ko\u017En\u00ED zm\u011Bny a\u017E stupn\u011Bm 3 a 4 dle WHO. Stav jsme hodnotili jako kombinovan\u00FD toxick\u00FD \u00FA\u010Dinek gemcitabinu a vinorelbinu v ter\u00E9nu k\u016F\u017Ee po\u0161kozen\u00E9 preexistuj\u00EDc\u00ED ichty\u00F3zou. Po odezn\u011Bn\u00ED ko\u017En\u00ED toxicity bylo zbytkov\u00E9 uzlinov\u00E9 posti\u017Een\u00ED oz\u00E1\u0159eno."@cs . "Hodgkin lymphoma; ichthyosis; gemcitabine; vinorelbine"@en . "\u010Casopis l\u00E9ka\u0159\u016F \u010Desk\u00FDch" . "CZ - \u010Cesk\u00E1 republika" . . . "352780" . "Hodgkin lymphoma was histologically proven in a 47-year-old male patient with a long-lasting history of ichthyosis. Patient was treated with six cycles of combined chemotherapy. 15 months after initial treatment the first relapse of Hodgkin lymphoma was confirmed. Patient was successfully treated with six cycles of chemotherapy followed by radiotherapy. The above mentioned chemotherapies did not cause serious cutaneous toxicity. 4 years after previous therapy the second relapse of Hodgkin lymphoma occurred. Patient was treated with three cycles of combined chemotherapy: ifosfamide, gemcitabine, vinorelbine and prednisone. This chemotherapy caused neutropenia WHO grade 4 after each cycle and a serious diffuse toxoallergic cutaneous reaction with bullous erythema developed. Several skin lesions fulfilled criteria for cutaneous WHO grade 3 and 4 toxicity."@en . "RIV/00216208:11110/09:5813!RIV10-MSM-11110___" . . "2009" . . "Z\u00E1va\u017En\u00E1 ko\u017En\u00ED toxicita po l\u00E9\u010Db\u011B ifosfamidem, gemcitabinem a vinorelbinem u pacienta s relapsem Hodgkinova lymfomu a ichty\u00F3zou" . "Serious cutaneous toxicity following ifosfamide, gemcitabine and vinorelbine therapy in a patient with relapsed Hodgkin lymphoma and ichthyosis]"@en . "0008-7335" . . "Z\u00E1va\u017En\u00E1 ko\u017En\u00ED toxicita po l\u00E9\u010Db\u011B ifosfamidem, gemcitabinem a vinorelbinem u pacienta s relapsem Hodgkinova lymfomu a ichty\u00F3zou" . . . . "2"^^ . . "St\u0159\u00EDtesk\u00FD, Jan" . . . . "[392F1DE734A0]" . "3"^^ . "RIV/00216208:11110/09:5813" . .